ACHV

ACHV

USD

Achieve Life Sciences Inc. Common Shares

$2.640-0.210 (-7.368%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.850

最高

$2.850

最低

$2.470

交易量

2.84M

公司基本面

市值

131.2M

行業

生物科技

國家

United States

交易統計

平均交易量

0.78M

交易所

NCM

貨幣

USD

52週範圍

最低 $1.84當前 $2.640最高 $5.31

相關新聞

GlobeNewswire

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and

查看更多
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
GlobeNewswire

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherapy option for

查看更多
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
GlobeNewswire

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more

查看更多
Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
GlobeNewswire

Achieve Life Sciences Announces Proposed Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and

查看更多
Achieve Life Sciences Announces Proposed Underwritten Public Offering